The first thing most owners notice is a sound. A faint scrape on the pavement, once every few steps, from one back paw. Then the toenails on that foot start wearing down at an angle. The dog is nine or ten, still eating well, still keen for walks, and shows no sign of discomfort — so it gets filed under "getting older" or "a bit of arthritis," and months pass.

Degenerative myelopathy is the diagnosis that hides inside that assumption. It's a progressive disease of the spinal cord's white matter, and it is the closest naturally occurring animal model of amyotrophic lateral sclerosis (ALS) — Lou Gehrig's disease — that we know of. It doesn't hurt, which is exactly why it's missed. And while nothing stops it, what you do in the first few months measurably changes how long your dog keeps walking.

What Is Actually Happening in the Spinal Cord

In DM, the myelin sheaths and axons of the spinal cord degenerate, beginning in the thoracolumbar region — the mid-to-lower back. Because these are the tracts carrying movement commands down to the hind legs and position information back up to the brain, the dog progressively loses two things at once: coordination and strength.

Crucially, the sensory pathways for pain are largely spared. Your dog isn't stoically enduring anything; the disease genuinely doesn't hurt. That distinguishes it from the conditions it's most often confused with — intervertebral disc disease, lumbosacral stenosis, hip dysplasia and arthritis all typically produce pain, reluctance to be touched, or a yelp on movement. A dog whose back legs are failing but who never flinches is a dog whose vet should be thinking about DM.

The Genetics: What the SOD1 Test Does and Doesn't Tell You

In 2009, a research team led by Awano and Coates published a genome-wide association study in PNAS that traced DM in Pembroke Welsh Corgis to a mutation in the SOD1 gene — a c.118G>A substitution changing one amino acid in superoxide dismutase 1, the enzyme that neutralises superoxide radicals in the nervous system. Mutations in the very same gene cause a common inherited form of human ALS. A second variant, SOD1B (c.52A>T), was later found exclusively in Bernese Mountain Dogs.

The mutation is inherited in an autosomal recessive pattern with incomplete penetrance, and that phrase carries all the practical weight. Dogs with two copies are considered at risk — but many never develop clinical signs at all. Carriers with a single copy are usually spared, though not always, and tend to progress more slowly if affected. A large survey of SOD1 allele distribution across more than 200 breeds found the at-risk variant in over a hundred of them, including a great many mixed-breed dogs.

So a positive genetic result is a risk flag, not a diagnosis, and it should never on its own justify euthanasia, breeding decisions made in panic, or writing off a healthy dog. Conversely, a "clear" result is genuinely useful: it makes DM very unlikely and pushes the search back toward treatable causes.

Which Dogs Get It, and When

Onset is typically eight years or older, with a mean around nine in large breeds, though signs can begin as early as five. Cornell's Riney Canine Health Center lists German Shepherd Dogs, Boxers, Pembroke Welsh Corgis, Chesapeake Bay Retrievers, Rhodesian Ridgebacks and Bernese Mountain Dogs among the predisposed breeds, and Standard Poodles and Wire Fox Terriers are also well represented. Corgis carry a genetic modifier that shifts onset earlier.

Small breeds are not immune, and they tend to progress more slowly — sometimes over years rather than months.

The Four Stages

Clinicians usually describe DM in four phases, and knowing them helps you plan rather than react:

  1. Early (ambulatory paraparesis). Wobbliness in the hind end, scuffed nails, knuckling of a paw, crossing the back legs, difficulty rising, swaying when turning. Often asymmetric — one leg worse than the other. This stage commonly lasts several months.
  2. Non-ambulatory paraparesis to paraplegia. The dog can no longer support its own weight behind and needs a sling or a cart. Urinary and faecal continence often start to slip.
  3. Ascending involvement. The degeneration climbs. Hind limbs become flaccid rather than stiff, muscle wastes visibly, reflexes disappear, and weakness begins to show in the front legs.
  4. End stage. Widespread paralysis, difficulty holding the head up, and eventually compromised swallowing and breathing.

Most dogs lose the ability to walk within six to twelve months of the first signs, though the range spans roughly six months to three years. In practice, the great majority of owners choose humane euthanasia during stage two or three, when nursing needs outpace quality of life.

Why the Diagnosis Is One of Exclusion

There is no test that confirms DM in a living dog. Definitive diagnosis requires microscopic examination of the spinal cord after death. What a vet can do — and should do — is systematically rule out the conditions that are treatable and can look identical early on: intervertebral disc disease, spinal tumours, lumbosacral disease, fibrocartilaginous embolism, and orthopaedic problems in the hips and knees.

That workup usually means a full neurological examination, bloodwork, radiographs, and advanced imaging — MRI or CT — sometimes with cerebrospinal fluid analysis. In DM, the imaging is characteristically normal, or shows incidental changes too mild to explain the signs. That normal scan, combined with a compatible history, painless progression and an at-risk genotype, is what makes a presumptive diagnosis credible.

Skipping the imaging is the expensive mistake. A compressive disc lesion mislabelled as DM is a dog that could have been helped and wasn't.

What Actually Helps

No drug, supplement or diet has been shown to halt or reverse DM. Aminocaproic acid, N-acetylcysteine and vitamin regimens have all been tried without convincing evidence. What does have evidence behind it is physiotherapy.

A 2006 study by Kathmann and colleagues in the Journal of Veterinary Internal Medicine examined 50 dogs with suspected DM and assessed physiotherapy in 22 of them. Dogs receiving intensive, daily controlled physiotherapy survived a mean of 255 days, compared with 130 days for moderate physiotherapy and just 55 days for none. The study was small and not randomised, and owner motivation certainly confounds it — but it remains the strongest signal we have, and it is consistent with everything we know about maintaining muscle mass in a neurodegenerative disease.

Practical measures that make the biggest difference day to day:

The Bottom Line

If an older dog's back end is failing and nothing seems to hurt, degenerative myelopathy belongs on the list — and getting there early matters, because the window in which physiotherapy and home modifications do the most good is the window most often spent waiting to see whether it gets better. It doesn't get better. But dogs with DM can have good, engaged, comfortable months and sometimes years, and the ordinary work of harnesses, traction, daily exercise and a well-timed cart is what buys them.

Ask for the neurological exam. Ask about imaging before accepting the diagnosis. And if your breed is on the list, the SOD1 test is worth doing while your dog is still young — not to predict the future, but to know which conversation you're having.